Skip to main content
. Author manuscript; available in PMC: 2010 Apr 21.
Published in final edited form as: Neurology. 2007 Nov 6;69(19):1873–1880. doi: 10.1212/01.wnl.0000279333.77404.d7

Table 3.

Results from final model including the interaction between baseline statin use and LDL-C on 3-year cognitive decline

Parameter
estimate		 Standard
error		 p Value*
Age at baseline 0.02 0.01 0.0003
Female 0.01 0.06 0.8269
Years of education −0.02 0.01 0.1543
Any ApoE ε4 allele 0.16 0.06 0.0110
LDL-C >130 mg/dL −0.05 0.16 0.7874
Use of statins at baseline −0.16 0.08 0.0415
Use of statins at baseline and LDL-C interaction −0.05 0.18 0.7605
*

p Values are from the Type III tests from the analysis of covariance model including the interaction of statin use and low-density lipoprotein cholesterol (LDL-C).